Technical Analysis for WXIBF - Wuxi Biologics Cayman Inc

Grade Last Price % Change Price Change
grade A 16.5216 -4.33% -0.7484
WXIBF closed down 4.33 percent on Friday, May 22, 2020, on 24.61 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical WXIBF trend table...

Date Alert Name Type % Chg
Stochastic Sell Signal Bearish 0.00%
Volume Surge Other 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
New 52 Week Closing High Bullish -4.33%
Narrow Range Bar Range Contraction -4.33%
New 52 Week High Strength -4.33%
Older signals for WXIBF ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

WuXi Biologics (Cayman) Inc., an investment holding company, provides discovery, research, development, and manufacturing of biologics services. It offers clinical and commercial manufacturing, assay, formulation and process development, assay and process validation, protein, monoclonal antibodies and cGMP drug substances manufacturing, lot release testing, stability studies, drug product formulation, fill and finish, and regulatory support services. The company also provides consultation services for biopharmaceutical technology, sales and marketing, and international sales contracting service; and produces and sells medicals. It serves pharmaceutical and biotechnology companies. WuXi Biologics (Cayman) Inc. has a strategic collaboration with Bioasis Technologies Inc. to develop and manufacture xB3-001 to treat cancer; CANbridge Pharmaceutical Inc. to develop and commercialize a portfolio of iotherapeutics for the treatment of rare diseases; ABL Bio Corporation to develop bispecific antibodies; AC Immune SA for biologics discovery, development, and manufacturing; Oxford BioTherapeutics for developing bispecific antibodies; and Amicus Therapeutics, Inc. The company was founded in 2014 and is headquartered in Wuxi, China. WuXi Biologics (Cayman) Inc. is a subsidiary of WuXi Biologics Holdings Limited.
Manufacturing Biotechnology Cancer Nature Biopharmaceutical Biology Antibodies Consultation Services Monoclonal Antibody Rare Diseases

Is WXIBF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.27
52 Week Low 6.2
Average Volume 15,032
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 12.9537
10-Day Moving Average 14.5482
Average True Range 0.8651
ADX 19.35
+DI 61.9079
-DI 33.4657
Chandelier Exit (Long, 3 ATRs ) 14.6747
Chandelier Exit (Short, 3 ATRs ) 11.7953
Upper Bollinger Band 17.4112
Lower Bollinger Band 8.4962
Percent B (%b) 0.9
BandWidth 68.8220
MACD Line 1.7491
MACD Signal Line 1.4531
MACD Histogram 0.296
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.5216
Resistance 3 (R3) 16.5216 16.5216 16.5216
Resistance 2 (R2) 16.5216 16.5216 16.5216 16.5216
Resistance 1 (R1) 16.5216 16.5216 16.5216 16.5216 16.5216
Pivot Point 16.5216 16.5216 16.5216 16.5216 16.5216
Support 1 (S1) 16.5216 16.5216 16.5216 16.5216 16.5216
Support 2 (S2) 16.5216 16.5216 16.5216 16.5216
Support 3 (S3) 16.5216 16.5216 16.5216
Support 4 (S4) 16.5216